A sample report on
UAE Nutritional
Supplements Market
Analysis
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F)
www.insights10.com
This report presents a strategic analysis of the UAE Nutritional Supplements Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, types of clinical diagnostics, point-of-care testing, main players, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the UAE Nutritional Supplements Market, and offers unmatched value, accuracy, and expert insights
Report Scope
Report Attribute
Details
Number of Pages
70-80
Base Year for Estimation
2022
Forecast Period
2023-2030
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Report Coverage
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Research Approach
Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 3
Table of Content
CONTENT
PG. NO.
1. Nutritional Supplements Overview
12-25
1.1. Overview
1.2. UAE Overview
1.3. Economic Overview: UAE
1.4. Nutritional Supplements Market in UAE
1.5. OTC & Nutraceuticals Market in UAE
1.6. Healthcare Scenario in UAE
1.7. Health Insurance Coverage: UAE
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting
26-32
2.1 Market size and forecasts (Excel and Methodology)
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 4
Table of Content
CONTENT
PG. NO.
2.2. Market Segmentation
2.2.1. Technology Outlook
2.2.2. By Consumer Group
2.2.3. ByFormulations
2.2.4. By Delivery Channel
3. Market Dynamics
33-37
3.1. Market Growth Drivers
3.1.1. Increasing Health Consciousness
3.1.2. Rising Prevalence of Lifestyle Diseases
3.1.3. Medical Recommendations and Prescription
3.2. Market Restraints
3.2.1. Strict Regulations
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 5
Table of Content
CONTENT
PG. NO.
3.2.2. Lack of Awareness
3.2.3 Price Sensitivity
4. Competitive Landscape
38-48
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Amway
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. Herbalife
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 6
Table of Content
CONTENT
PG. NO.
4.2.2.1. Overview
4.2.2.2. Product Applications & Services
4.2.2.3. Recent Developments
4.2.2.4. Partnerships Ecosystem
4.2.2.5. Financials (Based on Availability)
4.2.3. Forever Living
4.2.3.1. Overview
4.2.3.2. Product Applications & Services
4.2.3.3. Recent Developments
4.2.3.4. Partnerships Ecosystem
4.2.3.5. Financials (Based on Availability)
4.2.4. Nature's Bounty
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 7
Table of Content
CONTENT
PG. NO.
4.2.4.1. Overview
4.2.4.2. Product Applications & Services
4.2.4.3. Recent Developments
4.2.4.4. Partnerships Ecosystem
4.2.4.5. Financials (Based on Availability)
4.2.5. GNC
4.2.5.1. Overview
4.2.5.2. Product Applications & Services
4.2.5.3. Recent Developments
4.2.5.4. Partnerships Ecosystem
4.2.5.5. Financials (Based on Availability)
4.2.6. Optimum Nutrition
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 8
Table of Content
CONTENT
PG. NO.
4.2.6.1. Overview
4.2.6.2. Product Applications & Services
4.2.6.3. Recent Developments
4.2.6.4. Partnerships Ecosystem
4.2.6.5. Financials (Based on Availability)
4.2.7. Nutrilite
4.2.7.1. Overview
4.2.7.2. Product Applications & Services
4.2.7.3. Recent Developments
4.2.7.4. Partnerships Ecosystem
4.2.7.5. Financials (Based on Availability)
4.2.8. Muscletech
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 9
Table of Content
CONTENT
PG. NO.
4.2.8.1. Overview
4.2.8.2. Product Applications & Services
4.2.8.3. Recent Developments
4.2.8.4. Partnerships Ecosystem
4.2.8.5. Financials (Based on Availability)
4.2.9. Life Extension
4.2.9.1. Overview
4.2.9.2. Product Applications & Services
4.2.9.3. Recent Developments
4.2.9.4. Partnerships Ecosystem
4.2.9.5. Financials (Based on Availability)
4.2.10. Swisse
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 10
Table of Content
CONTENT
PG. NO.
4.2.10.1. Overview
4.2.10.2. Product Applications & Services
4.2.10.3. Recent Developments
4.2.10.4. Partnerships Ecosystem
4.2.10.5. Financials (Based on Availability)
5. Reimbursement Scenario
49-56
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Diagnosis
5.3. Reimbursement Process for Treatment
5.4 Reimbursement Process – Medicare
5.5 Reimbursement Process - Medicaid
6. Methodology & Scope
57-62
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 11
UAE Nutritional Supplements Market Analysis
1. Nutritional Supplements Overview
1.1 Statistics at a Glance: The Burden of Nutritional deficiencies in the World Prevalence of Nutritional Deficiencies
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
25%
3rd
42%
of people affected iron
of the world’s population
of people deficient of
▪
In this section you will get an
deficiency worldwide
affected by Iodine
vitamin D in the US
understanding of the topic, which includes
deficiency
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
80–90%
44–50%
15% and 10%of
of vegetarians and
of preschool-aged
teenage girls and over
▪
In order to obtain access to all of the
vegans may be
children in certain
50 aged women
information that you are seeking, you will
deficient in vitamin
regions have vitamin A
recommended calcium
need to purchase the final report
B12
deficiency in developing
intake respectively in the
▪
Final report will be comprehensive and
countries
US
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 13
1.1 Overview of Nutritional Supplements Market in the World (continued) Europe
~Revenue to reach
$xx Bn by 2027
North America
~ Market Size of
Asia
$xx Bn
-Fastest CAGR
Africa
~Market Size of $xx
Middle East
Bn
~$xx Bn Market
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 14
1.2 UAE Overview
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In this section you will get an
understanding of the demographics of the
country/region, which includes the
9.37 Mn
$498.98 Bn
population, GDP, healthcare expenditure
and other details related to the topic
Is the population of
GDP in 2022
UAE, in 2021
▪
In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
28.2
$47,792
detailed, and it will include data, analysis,
is the median age
GDP per Capita in
trends, and other relevant information
in UAE, in 2022
2022
related to the topic or subject matter of
interest
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 15
1.3 Economic Overview: UAE
Population of UAE, (2020-2030)
GDP of UAE, (2020-2030)
XX
XX
XX
XX
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population Split (2023)
▪
In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, By Gender
By Age Group
healthcare expenditure and other details related to the topic
▪
In order to obtain access to all of the information that you are 0-14
seeking, you will need to purchase the final report
15-24
Female
Male
▪
Final report will be comprehensive and detailed, and it will 51%
49%
25-54
include data, analysis, trends, and other relevant information 55-64
related to the topic or subject matter of interest
65+
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 16
1.4 Statistics at a Glance: The Burden of Nutritional deficiencies in UAE
Prevalence of Nutritional Deficiencies and Dietary
Supplements Use in UAE
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
24.3%
35.6%
analysis that will be presented in the
of women aged 15 to 49
aged 18 to 24 years are
final report
years affected by anemia
using dietry supplements in
due to iron deficiency
UAE
▪
In this section you will get an
understanding of the topic, which
includes the prevalence of the disease,
90%
29.4%
the application of medical devices, new
of UAE population Vitamin D
males preferred protein
technology, and other details related to
deficient
supplements
the topic in UAE
▪
In order to obtain access to all of the
22%
29.4%
information that you are seeking, you
of the infants were anemic
males preferred protein
will need to purchase the final report
supplements
▪
Final report will be comprehensive and
6%
68.3%
detailed, and it will include data,
Dietary supplements users agreed
analysis, trends, and other relevant
Infants were wasted
its essential
information related to the topic or
subject matter of interest
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 17
1.5 OTC & Nutraceuticals in UAE
UAE OTC & Nutraceuticals Market Forecast, 2022-2030 (in $Bn) XX
XX
XX
XX
XX
XX
XX
XX
XX
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In this section you will get an understanding of the overall OTC & Nutraceuticals market in UAE, which includes the market size, current trends and other details related to the topic
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 18
1.6 Healthcare Scenario in UAE
▪
UAE has state-of-the-art healthcare infrastructure, including modern hospitals, clinics, and specialized medical centers. The country has established free zones such as Dubai Healthcare City and Abu Dhabi Health Services Company (SEHA) to attract international healthcare providers and promote medical tourism
▪
UAE has a dual healthcare system consisting of public and private sectors. The Ministry of Health and Prevention (MOHAP) oversees public healthcare facilities, which provide subsidized or free services to Emirati citizens
▪
AE places a strong emphasis on healthcare quality and accreditation. The Dubai Health Authority (DHA) and the Health Authority Abu Dhabi (HAAD) regulate healthcare providers and ensure adherence to international standards
▪
Health insurance is mandatory for residents in the UAE. Employers are generally responsible for providing health insurance coverage to their employees
In the United Arab Emirates (UAE), the drug approval process is overseen by the Ministry of Health and Prevention (MOHAP) Evaluation and
▪
The MOHAP evaluates the submitted data, including preclinical and clinical trial results, to assess the drug's safety, Assessment
efficacy, and quality.
Expert Committee
▪
The MOHAP may convene an expert committee or advisory board comprising healthcare professionals, scientists, Review
and regulatory experts to provide their opinions and recommendations on the drug's approval
▪
Based on the evaluation and expert committee recommendations, the MOHAP makes a decision regarding the Approval Decision
drug's approval
Post-Marketing
▪
Once a drug is approved and available in the market, the MOHAP continues to monitor its safety and effectiveness Surveillance
through post-marketing surveillance
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 19
1.6 Healthcare Scenario: Nutritional Deficeiency Patient Journey Symptom Recognition & Concern
Primary Care Consultation
Assessment & Initial Tests:
Test Results & Diagnosis
• Based on the patient's symptoms
• Patient schedules an appointment
• Once the test results are available, the
and medical history, the doctor
• Patient experiences symptoms that
with a primary care physician or
doctor reviews them and makes a
assesses the likelihood of a
may indicate a nutritional deficiency,
general practitioner
diagnosis regarding the presence and
nutritional deficiency
such as fatigue, weakness, hair loss, or
severity of the nutritional deficiency
specific signs related to a particular
•
During the consultation, the patient
• Doctor recommends initial blood
deficiency
describes their symptoms, medical
tests or other diagnostic
• They explain the implications of the
history, and any relevant dietary or
investigations to evaluate the
deficiency to the patient and discuss
lifestyle factors
patient's nutrient levels or screen for
potential causes
• Patient recognize these symptoms and
potential deficiencies.
• The doctor listens to the patient's
become concerned about their health
concerns and conducts a physical
• This may include tests for iron,
• The patient is informed about the
examination
vitamin D, vitamin B12, folate, or
importance of proper nutrition and the role
other relevant markers
it plays in overall health.
Treatment Plan Development
Referral to a Specialist
Follow-Up and Monitoring
▪ Doctor develops a treatment plan tailored to the patient's
▪ In some cases, the primary care
▪ Patient is scheduled for follow-up
specific nutritional deficiency. This plan may involve dietary physician may refer the patient to a
visits to monitor their progress and
modifications, lifestyle changes, and/or nutritional
specialist, such as a dietitian or
evaluate the response to treatment.
supplements
nutritionist, to provide more
▪ During these visits, the doctor or
▪ Doctor provides detailed instructions on dietary
specialized care and expertise
specialist assesses the patient's
recommendations, including specific foods to include or
▪ The specialist can further evaluate the
nutrient levels through repeated
avoid to address the deficiency
patient's nutritional needs, develop a
blood tests, discusses any challenges
▪ They may also refer the patient to a dietitian or nutritionist personalized meal plan, and offer
or concerns, and makes adjustments
for further guidance
ongoing support and monitoring
to the treatment plan as necessary
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 20
1.7 Health Insurance Coverage: UAE
% of People by Type of Health Insurance Coverage
Number of People By Health Insurance Coverage
(2021)
Coverage Type
2020
2021
Change %
Uninsured
8.3
Total
327,521
328,074
With health insurance
91.7
Any health plan
299,230
300,887
0.4
Any private plan
217,896
216,366
–0.6
Any private plan
66.0
Employment-based
178,737
178,285
–0.2
Employment-based
54.3
Direct-purchase
10.2
Direct-purchase
33,869
33,555
–0.1
Marketplace
3.5
Marketplace coverage
10,924
11,389
0.1
TRICARE
2.5
TRICARE
9,165
8,299
–0.3
Any public plan
112,925
117,095
1.2
Any public plan
35.7
Medicare
58,541
60,226
0.5
Medicare
18.4
Medicaid
58,778
61,940
0.9
Medicaid
18.9
VA and CHAMPVA
2,967
3,151
0.1
VA and CHAMPVA
1.0
Uninsured
28,291
27,187
–0.4
▪
In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year
▪
More people had private health insurance (66%) than public coverage (35.7%)
▪
Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%)
This is the US Health Insurance coverage, you will get UAE Health Insurance coverage in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 21
1.8 Budget of UAE Government for Public Insurance
Proposed Budget By Category
Outlays
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2022-31
Medicare
$769
$709
$766
$841
$840
$947
$1,014
$1,085
$1,227
$1,178
$1,325
$1,412
$10,633
In Billions Of Dollars
Medicaid
$458
$521
$571
$582
$616
$645
$674
$698
$734
$768
$801
$837
$6,926
Medicare
3.7%
3.2%
3.3%
3.4%
3.3%
3.6%
3.7%
3.8%
4.1%
3.8%
4.1%
4.2%
3.7%
As % Of GDP
Medicaid
2.2%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.5%
2.5%
2.5%
2.5%
2.4%
▪
National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪
Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪
Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪
Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪
Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪
Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪
Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪
Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪
Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪
Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
This is the budget of the US govt. for public insurance, you will get UAE govt. for public insurance in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 22
1.9 Mergers and Acquisitions
RCM M&A Deal Value Trend ($Bn)
RCM M&A Deal Volume Trend
$16.7
112
107
107
110
89
$11.7
82
$10.5
$7.7
$6.8
$6.0
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
Buyer Composition: Strategic Vs Financial (2020)
Buyer Type by Deal Size
41%
41%
42%
39%
($Mn)
59%
59%
58%
61%
Strategic Buyers
Financial Buyers
$0- $25
$25-$50
$50-$100
$100+
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 23
1.9 Mergers and Acquisitions (continued)
Latest Deals In UAE
Company Name
Year
Key Pointers
▪
Abbott launched a brand-new Ensure formulation with HMB. As a science-based nutritional supplement, the new Ensure contains 32 essential nutrients such as protein, calcium, and vitamin D to help improve muscle and bone September 2022
strength. It contains HMB or hydroxy-methyl butyrate, a new ingredient that helps counteract muscle loss and increases the strength and power of the body
Abbott
▪
Optimum Nutrition, a Glanbia Performance Nutrition brand, launched its brand-August 2022:
new Gold Standard Protein Shake. The new drink has two flavors: chocolate and vanilla. Each serving contains 24 grams of protein.
Optimum Nutrition
▪
PharmaNutrics launched five different dietary supplements in the United States. SerotomixPlus, GlucanPlus, Gaba 600, EnergixPlux, and March 2022:
CurcumixPlux serve different purposes for fatigue, stress, musculoskeleton, and anti-inflammatory support.
PharmaNutrics
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 24
1.9 Mergers and Acquisitions (continued)
Latest Deals In UAE
Company Name
Year
Key Pointers
2023
2023
2023
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 25
UAE Nutritional Supplements Market Analysis
2. Market Size and Forecasting
2.1 Market size and forecasts (Excel and Methodology)
Click on the icon to know the
UAE Nutritional Supplements Market Forecast, 2022-2030 (in $Bn) methodology and assumption
▪
Please be aware that this sample report
XX
is intended to provide you with a brief
XX
overview of the kind of information and
analysis that will be presented in the
final report
▪
In this section you will get an
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
and other details related to the topic
2023
2024
2025
2026
2027
2028
2029
2030
▪
In order to obtain access to all of the
Major Markets Patient
2.74
2.82
2.90
2.94
2.98
3.02
3.07
3.12
information that you are seeking, you
(Mn)
will need to purchase the final report
UAE Patient Size (Bn)
0.51
0.61
0.68
0.69
0.70
0.71
0.72
0.73
▪
Final report will be comprehensive and
% of US Patients
18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
detailed, and it will include data,
analysis, trends, and other relevant
Global Market Size (Bn $)
3,620
3,780
3,950
4,128
4,314
4,508
4,711
4,937
information related to the topic or
subject matter of interest
UAE Market Size (Bn $)
61
74
84
87
91
95
99
106
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 27
2.2 Snapshot of Nutritional Supplements Market Segmentation By Product
By Consumer Group
By Formulations
By Delivery Channel
Chemists/
Sports Nutrition
Infant
Tablets
Pharmacists
Fat Burners
Children
Direct-to-Consumer
Capsules
Sales Payers
Dietary Supplements
Adults
Powder
E-commerce
Functional Foods
Pregnant
Softgels
Geriatric
Liquid
▪
In this section you will get an understanding of the segmentations which will cover the UAE Nutritional Supplements Market
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 28
2.2.1 Market Segmentation: By Product Type
UAE Nutritional Supplements Market Share, By Product Type (2022)
▪
Dietary supplements market in UAE is
a significant component of the overall
Functional Foods
cancer treatment market
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
Dietary
analysis that will be presented in the
Fat Burners
Supplements
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Sports Nutrition
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 29
2.2.2 Market Segmentation: By Consumer Group
UAE Nutritional Supplements Market Share, By Consumer Group (2022)
▪
Infants dietary supplements market in
UAE is a significant component of the
Geriatric
overall cancer market
▪
It has the maximum market share in
Pregnant
UAE nutritional supplements market
with approximately xx%
Infants
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
Adults
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Children
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 30
2.2.3 Market Segmentation: By Formulations
UAE Nutritional Supplements Market Share, By Formulations (2022)
▪
Tablets have the maximum market
share in UAE cancer market with
approximately xx%
Liquid
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
Softgels
Tablets
analysis that will be presented in the
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
Powder
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Capsules
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 31
2.2.4 Market Segmentation: By Delivery Channel
UAE Nutritional Supplements Market Share, By Delivery Channel (2022)
▪
E-Commerce have the maximum
market share in UAE cancer market
with approximately xx%
▪
Please be aware that this sample report
E-commerce
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
Chemists/
▪
In order to obtain access to all of the
Pharmacists
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Direct-to-
Consumer Sales
Payers
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 32
UAE Nutritional Supplements Market Analysis
3. Market Dynamics
3.1 Market growth drivers
3.1.1 70% feel more in control of their health and 95% show proactiveness in protecting their health, the research notes
▪
There has been a growing awareness of the importance of nutrition and Health Awareness Growth Rate
maintaining a healthy lifestyle among the population in the UAE
▪
Individuals are becoming more health-conscious and proactive in seeking ways to improve their overall well-being
▪
This increased focus on personal health and wellness has led to a greater demand for nutritional supplements as a means to support their dietary needs.
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 34
3.1 Market growth drivers (continued)
3.1.2 Noncommunicable diseases account for 76% of deaths in the UAE, and in recent years the country has seen a rapid increase in diseases such as diabetes and obesity.
▪
UAE has witnessed an increase in the prevalence of lifestyle Prevalence of Non-Communicable
diseases such as obesity, diabetes, and cardiovascular
Diseases in UAE
disorders
▪
These health concerns have prompted individuals to adopt
healthier lifestyles and seek ways to prevent and manage
these conditions
▪
Nutritional supplements, including vitamins, minerals, and herbal extracts, are seen as a convenient and accessible
option to complement a healthy diet and support overall
health.
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 35
3.1 Market growth drivers (continued)
3.1.3 Pharmacies across the UAE have been witnessing a marked increase sometimes as much as 100% in the annual demand for multivitamins and supplements that claim to boost immunity amid the global pandemic
▪
Healthcare professionals, including doctors, dietitians, and Healthcare professionals recommend
nutritionists, often recommend nutritional supplements to nutritional supplements in UAE
individuals with specific nutrient deficiencies, chronic
diseases, or during pregnancy and lactation
▪
These recommendations and prescriptions have played a
role in driving the demand for nutritional supplements in the UAE.
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 36
3.2 Market restraints
3.2.1 UAE has strict
3.2.2 Despite increasing health
3.2.3 Price sensitivity is a
regulations governing
consciousness, there is still a
significant constraint in the UAE
the sale, importation,
lack of widespread consumer
nutritional supplements market.
and marketing of
awareness of benefits of
nutritional supplements
nutritional supplements
▪
Stringent regulatory framework
▪
Many individuals may not be
▪
Some consumers may perceive
requires compliance with specific
aware of the specific nutritional
nutritional supplements as
labeling requirements, ingredient
deficiencies they may have or
expensive, particularly high-
standards, and product
the potential benefits of
quality and branded products
registrations
supplementing their diet with
▪
Affordability can be a challenge
▪
Obtaining necessary approvals
appropriate products
for individuals with limited
and complying with regulatory
▪
Insufficient education and
disposable income or those who
requirements can be time-
information about the importance
consider nutritional supplements
consuming and costly for
of proper nutrition and the
as discretionary spending
manufacturers and distributors
correct usage of supplements
▪
Price-conscious consumer
▪
Stringent regulations act as a
can hinder market growth and
mindset may lead to hesitation or
barrier to entry for some
consumer adoption
limited purchasing power,
companies and may limit the
impacting market growth.
variety of products available in
the market
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 37
UAE Nutritional Supplements Market Analysis
4. Competitive Landscape
4.1 Major Market Share
▪
UAE cancer market is a highly competitive
Revenue of Major players in UAE Nutritional Supplements Market ($ Mn) space, with many companies developing
and marketing cancer treatments
Company10
▪
Some of the top companies in UAE cancer
Company 9
market based on revenue and market
share include
Company 8
▪
In order to obtain access to all of the
Company 7
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
Company 5
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
Company 3
interest
Company 2
Company 1
XX
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 39
4.2 Key Company Profile
Key Note:
1
Amway
▪
Here is the list of top 10 companies which
will cover in the final report
2
Herbalife
▪
Each company will have slides for
o Overview
3
Forever Living
o Key details
4
Nature's Bounty
o Offerings
o Name of products
5
GNC
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
6
Optimum Nutrition
o Mergers, Acquisitions and
Collaboration
7
Nutrilite
o Financials
8
Muscletech
▪
If there are specific companies that you
would like to be included in the report,
please let us know via email
9
Life Extension
▪
In order to obtain access to all of the
information that you are seeking, you will
Swisse
10
need to purchase the final report
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 40
4.2.1 Amway
Key Executives
▪ Amway is a well-known global company that offers a range of Founded in: 1959
nutritional products under its Nutrilite brand.
➢ Milind Pant - CEO
HQ: Ada, Michigan, US
▪ Amway's Nutrilite products are formulated based on scientific
➢ Doug DeVos - Co-Chairman of
research and manufactured using high-quality ingredients
Type: Privately-held
the Board
▪ Company emphasizes the use of plant-based ingredients and
➢ Steve Van Andel - Co-Chairman
sustainable farming practices in the production of its supplements Revenue: $8.4 Bn
of the Board
▪ Nutrilite products undergo rigorous quality control processes to Website: www.amway.com
➢
ensure safety, purity, and potency
Samir Behl - Chief Financial
Officer (CFO)
Drugs for Cancer
Recent Activity / Press Coverage
Nutritional Education and
April 19, 2023: Amway has been named the No. 1 direct selling Nutritional Supplements
company in the world, according to the 2023 Direct Selling News Resources
Global 100 list based on 2022 revenue
Weight Management
Nutritional Analysis Tools
December 12, 2022: Amway launches Singapore Business Innovation Hub to accelerate health and wellness innovation Sports Nutrition
Weight Management Programs
Feb. 27, 2023: Amway, an entrepreneur-led health and wellness Personalized Nutrition
Community Support and
company, today reported sales of $8.1 billion USD for the year Consultations
Networking
ending December 31, 2022
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 41
4.2.1 Amway (continued)
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 42
4.2.1 Amway (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Company Name
Type
Year
Key Pointers
Duration
▪
Amway has committed to a second-round investment with
Holzapfel Effective Microbes (HEM), a company that supports August 15,
people with incurable diseases related to microbiome disfunction Partnership
-
2022
▪
HEM uses Personalized Pharmaceutical Meta-Analytical
Amway and HEM
Screening (PMAS) to determine how gut microbiota can be
leveraged to impact human health and wellness
▪
TC’s B Natural and Amway India collaborate to launch immunity offering in fruit beverages
▪
In a unique partnership, ITC’s B Natural and Amway India have collaborated to launch the first of its kind B Natural+ range for the Collabration
-
May 29, 2020
Indian consumer
Amway and ITC
▪
B Natural Juices & beverages, which believes in providing fruit nourishment to its consumers, intends to provide the dual benefit of Immunity + Fruit & Fiber to them with the launch of the B
Natural + range
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 43
4.2.1 Amway (continued)
Revenues ($Bn), 2020-2030
▪
Amway annual revenue for 2022 was
$8.9.Bn , a XX% increase from 2021.
TELUS annual revenue for 2021 was $XX
BN, a XX% increase from 2020.
8.9 Bn
XX
▪
Revenue generated by Telus Health in
XX
2022 reflects the company's continued
growth and success in the healthcare
industry
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
▪
In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Breakdown of Net Revenue by Segment, 2022
1
2
3
4
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 44
4.2.2 Company 2
Solutions offered by Company
Founded in:
HQ:
Type:
Revenue:
Website:
Drugs for Cancer
Recent Activity / Press Coverage
Drugs
Indications
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 45
4.2.2 Company 2 (continued)
Partnerships Ecosystem
Major Distribution Partners
Major Vendor Partners
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 46
4.2.2 Company 2 (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Company Name
Type
Year
Key Pointers
Duration
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 47
4.2.2 Company 2 (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
xx
xx
xx
report
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 48
UAE Nutritional Supplements Market Analysis
5. Reimbursement Scenario
5.1 Reimbursement Regulation
Medicare and Medicaid together provide
The reimbursement scenario in the US cancer market is complex and can vary health insurance coverage for more than
depending on the specific treatment, setting of care, and insurance coverage.
Here are some key points to consider:
4 in 10 Americans
▪
Medicare:
o Medicare is a federal health insurance program for people aged 65 and Other Public
older, as well as people with certain disabilities or health conditions 1%
o Medicare covers many cancer treatments, including chemotherapy, Other Private
radiation therapy, and some immunotherapies
3%
Uninsured
o
9%
However, coverage can be subject to strict guidelines and restrictions, Medicare
17%
such as the requirement for prior authorization
▪
Medicaid:
o Medicaid is a joint federal-state program that provides health insurance for people with low incomes
o Medicaid coverage for cancer treatments can vary by state, and may be Medicaid
and CHIP
subject to limits on the amount and type of treatment covered 21%
▪
Private Insurance:
o Private insurance coverage for cancer treatments can also vary widely depending on the insurer and the specific policy
Employer-Sponsored
49%
o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Health Insurance Coverage, 2022
This is the reimbursement regulation of of the US govt. for public insurance, you will get UAE reimbursement regulations in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 50
5.1 Reimbursement Regulation (continued)
▪
Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover certain preventive services, including cancer screenings, without co-pays or deductibles o It also includes protections for people with pre-existing conditions, such as cancer
▪
Reimbursement for New Treatments:
o Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage o This can create challenges for companies developing and marketing new treatments
▪
Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
This is the reimbursement regulation of of the US govt. for public insurance, you will get UAE reimbursement regulations in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 51
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population)
Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
100%
100%
100%
100%
100%
0%
Government Expenditure
0%
xx
xx
xx
xx
xx
7%
%
Public Healthcare
44.
0
8%
46.
.
47.
15
51.
Private Health Insurance
Coverage
Out of Pocket
Private Coverage
9%
1%
6%
5%
5%
38.
37.
35.
32.
31.
Other
NA
NA
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid
6.3%
4.08%
5.1%
3.8%
2.2%
2.4%
3.6%
GDP Growth (yoy)
Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 14.7%
11.3%
15.5%
7.5%
4.2%
NA
NA
HC Spend Growth (yoy)
Medicaid is a joint federal-state program that provides healthcare coverage to individuals with low income and limited resources
Reimbursement Market Trends
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 52
5.2 Reimbursement Process for Diagnosis of Cancer
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪
Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪
Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided
▪
Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud
▪
Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule
▪
Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
This is the reimbursement regulation of of the US govt. for public insurance, you will get reimbursement process in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 53
5.3 Reimbursement Process for Treatment of Cancer
The reimbursement process in the US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare FDA
provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪
Service or Treatment Provided: The healthcare provider performs a Market Authorization
service or treatment for the patient
▪
Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service Private Payers
Public Payers
provided
▪
Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment Health Technology Assessment
provided, and checking for any potential errors or fraud
▪
Payment: If the claim is approved, the insurance company or other 1
2
3
payer reimburses the healthcare provider for the service provided, Coding
Coverage
Payment
based on the negotiated payment rates or fee schedule
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
This is the reimbursement regulation of of the US govt. for public insurance, you will get UAE reimbursement process in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 54
5.4 Reimbursement Process - Medicare
Medicare
▪ 100% population is covered under this scheme
Population Covered
▪ Citizen’s contribute to this scheme which then earns an interest. There is Basic Healthcare Sum (BHS) cap which limits the maximum contribution to an individuals Medicare account
Provider Restrictions/
Services can be claimed from Medicare-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community Selection
center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers)
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits Services Covered
▪ Patients above 65 years of age can claim under Flexi-Medicare and further reduce their out-of-pocket expenses by using up to $200 per patient per year from their Medicare account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicare account; Drugs used for cosmetic purposes such as slimming pills and hair loss pills cannot be claimed from this account
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicare up to $500 per account per year, however a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures Level of Coverage/ Assurance
▪ Outpatient scans/ diagnostics for cancer up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month per patient
▪ Renal dialysis up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
▪ DRG with Activity Based Funding for public providers
Mechanism of Coverage
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility
▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
This is the reimbursement process of of the US govt. for public insurance, you will get Canada reimbursement process in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 55
5.5 Reimbursement Process - Medicaid
Medicaid
▪ 38% population is covered under this scheme
Population Covered
▪ Medicare covers individuals who are aged 65 and older, as well as those with certain disabilities or end-stage renal disease Provider Restrictions/
Services can be claimed from Medicaid-approved institutions only (14 public hospitals, 10 private hospitals, 7 public community centers, 1 private community Selection
center and over 100 surgery centers, dialysis centers, colonoscopy centers and screening centers)
▪ Medicines under SDL and MAF Plus can be bought from the money saved in this account
▪ Money can be also be claimed for antiretroviral drugs for HIV, Desferrioxamine drug for treatment of thalassemia and immuno-suppressant drugs for organ transplant
▪ Money from this account can be used to pay Medishield premiums and Integrated Shield Plan premiums, subject to withdrawal limits Services Covered
▪ Patients above 65 years of age can claim under Flexi-Medicaid and further reduce their out-of-pocket expenses by using up to $200 per patient per year from their Medicaid account
▪ Excluded: Traditional drugs such as Herbal and Ayurveda cannot be claimed from Medicaid account; Drugs used for cosmetic purposes such as slimming pills and hair loss pills cannot be claimed from this account
▪ Approved chronic conditions and vaccinations, health screenings as outpatient treatments can be paid with Medicaid up to $500 per account per year, however a cash copayment of 15% is applicable
▪ Inpatient hospitalization, up to $450 per day + surgical limits according to Table of Surgical Procedures
▪ Approved day surgeries up to $300 per day + surgical limits according to Table of Surgical Procedures Level of Coverage/ Assurance
▪ Outpatient scans/ diagnostics for cancer up to $600 per year per patient, and up to $300 for other medical conditions
▪ Chemotherapy (includes analgesic medication and suppressive treatments such as neuroendocrine and nuclear medicine treatments) up to $1,200 per month per patient
▪ Renal dialysis up to $450 per patient per month
▪ Other treatments are also approved with various sub-limits for withdrawal
▪ DRG with Activity Based Funding for public providers
Mechanism of Coverage
▪ Block funding with DRG for providers not covered under ABF
Financial Feasibility
▪ The Basic Healthcare sum has been increased by more than 4.4% in 2017 on account of increasing costs of healthcare. This is an individual account
This is the reimbursement process of of the US govt. for public insurance, you will get Canada reimbursement process in Final Report
Illustrative
A Sample Report on UAE Nutritional Supplements Market Analysis I Confidential 56
UAE Nutritional Supplements Market Analysis
6. Methodology & Scope
▪
Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions
▪
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources
▪
For forecasting, the following parameters are considered:
❑
Market drivers and restraints along with their current and expected impacts
❑
Technological scenario and expected developments
❑
End use industry trends and dynamics
❑
Trends in the consumer behavior
❑
Regulatory scenario and expected developments
❑
Current capacity and expected capacity additions up to 2030
▪
We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions
▪
All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪
Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
Analysis Methodology
Our Analysis Methodology involves three critical stages:
Data
Market Data Analysis
Interpretation &
Collection
& Statistical Model
Presentation
Secondary
Analysis &
Market Trends
Research
Interpretation
Primary
Market Sizing &
Insights
Research
Analysis
Proprietary
Data Triangulation &
Presentation &
Database
Validation
Reporting
Data Triangulation & Data Validation
Top Down Approach
Final
Final Market size break up to
Market
rest of segmentation
Size
Validation from
Arriving at market size
Primary Interview
of each segment
Summarization of revenue
generated from companies
Validation from
to arrive at total market size
Primary Interview
Revenue generated by products &
Final
services offered by companies
Summary
Bottom Up Approach
Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Base Year for
2022
Estimation
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Report Coverage
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
Customized Report
that is currently not a part of our scope as a
2023-
Forecast
part of customization
2030
Period
Pricing and purchase
Avail customized purchase options to meet
options
your exact research needs
A division of
Lifesciences Market
Research Reports you
can trust
Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get actionable insights to
take informed business
decisions
A large database of over 30,000 syndicated
market research reports in OTC & Nutraceuticals and healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Elevate your business plans
with in-depth market analysis
and industry intelligence
Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Gain a competitive edge with
Insights10's customized
healthcare research solutions
Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Market Research Reports
across various categories
OTC & Nutraceuticals
Digital
Medical
Healthcare
OTC &
Clinical
(Diseases & Drugs)
Health
Devices
Services
Nutraceuticals
Trials
FEATURED REPORTS
FREE SAMPLE REPORTS
TRENDING TOPICS
What makes us different?
30000+
22000+
2000+
1200+
Life science
Country
Rare & orphan
Reports
Market Research
Specific
Disease
Published
Reports
Reports
Reports
Annually
Table of Contents
Market Overview
Competitive Landscape
1
6
Growth Drivers &
Key Company Profiles
2
7
Growth Restraints
Epidemiology &
Policy & Regulatory
3
8
Disease type
Landscape
insights on
which our
reports are
Market Segmentation
based
4
9
Reimbursement Scenario
Market Share
5
10
Factors Driving Future Growth
Our Services
Market Research
Customized
Primary
Reports
Reports
Research
Database
Full-Time
Conference
Service
Engagement
Coverage
Competitive
Regulatory
Subscription
Intelligence
Compliance
Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions
Research Projects Done
Our Research Process
01
02
03
04
05
Identification of
Market
Collection of
Collaboration
Verification &
Data
Dynamics
Data
of Data
Analysis
Statistical Databases
Company Websites/Annual Reports
Data
Sources
Trade Publications
We have access to multiple highly
Online Databases
reliable free and subscription data
sources. We have many years of
experience to understand which
Published Research Reports
sources are more dependable for what
and which to prefer for the reliable and
Whitepapers
latest information.
Press Releases of Key Market Players
What kind of data is presented
in our reports?
Our reports present data, which is:
Reliable
Expert-verified
Real
Comprehensive
Easy to read
The report is
The data is prepared
Allowing you to
Covers everything
You do not have to
prepared using a
by a team of highly
confidently make
you would need to
be a market expert
proven methodology
qualified &
smarter business
know about the
to understand what
and insightful
experienced research
and strategic
market including
really is happening
research
analysts & vetted by
decisions
market size,
on the market and
our local associates
competitive analysis
how it works
& much more
The team
“The business decision-making process is no longer as straightforward as it used to be. It requires insights generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with some of the best organizations in the world,
generating insights that provides substantial competitive advantage.”
Dr. Purav Gandhi
Founder & CEO
Leadership Team
Dr. Purav Gandhi
Anish Swaminathan
Mukesh Nayak
Ritu Baliya
Founder & CEO
Director
Head – Marketing & Research
Engagement Manager
Purav is a physician and an entrepreneur
Anish has 15+ years of experience
Mukesh is an engineering graduate with
Ritu has over 6 years of experience in
with 12+ years of experience in Healthcare
in management consulting in the
an MBA in Marketing. He is a seasoned
strategy building, market assessments,
& Life Sciences industry spanning across
Life Sciences sector, and has
healthcare market research & marketing
market sizing, and RWE for global MNC
strategy, market access, health informatics
worked with diverse multinational
professional with a progressive
healthcare & biopharma clients across diff.
and RWE, digital health, analytics and data
firms in the US, India, Middle East
experience of over 20 years in Life
markets (America, Europe, Africa, APAC
science. Purav studied medicine from
and APAC regions. His primary
Sciences, Pharma and Medical Device
and Middle East). Her areas of expertise
Gujarat University and also completed his
area of interest is Customer and
sectors. With an in-depth understanding
include: Indentifying emerging trends in life
MBA from IIM-Kozhikode. Purav started
Market Strategy, Market Access,
of primary research, he has conducted
sciences industry, Competitor landscape
his career with Deloitte working on strategy
and Digital Health with special
hundreds of interviews of various
assessment, Disease opportunity
consulting engagements and also co-
focus on emerging markets like
stakeholders in pharma & healthcare &
assessments etc. She is a pro in secondary
founded ConvergeHealth by Deloitte.
Africa, Middle East and APAC.
completed several research projects
and primary research with a deep domain
across life sciences industry.
expertise in healthcare sector.
Our Team
Our Clients
Our Clients
… and many more
Do you have
any questions?
We would be happy to help.
Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
Thank you
We truly appreciate your business and
look forward to serving you.
www.insights10.com
